GlassScriptPhysician profile
Leonard Y Cosmo
NPI 1891763934
$13,767.50
in general payments reported to CMS, 2019-2025
54 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $1,868 · 2021: $1,875 · 2022: $2,254 · 2023: $1,963 · 2024: $2,033 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,220 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,219.87 |
| Education | $110.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,319.88 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $2,105.88 | 2019-2025 | Trelegy Ellipta, Nucala |
| Harmony Biosciences LLC | $1,061.25 | 2020-2025 | Wakix |
| Insmed, INC. | $864.59 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $711.68 | 2021-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $635.85 | 2019-2024 | Glassia |
| Regeneron Healthcare Solutions, INC. | $623.92 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $575.98 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $485.79 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.84 | 2019-2025 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Abbvie INC. | $400.40 | 2021-2025 | Ubrelvy, Linzess, Creon |
| Genzyme Corporation | $375.38 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $333.24 | 2019-2025 | Uptravi, Opsumit |
| Philips North America LLC | $259.87 | 2019-2025 | (Ae4) Secretion Management, Image Management Subscription, Vest Therapy Und |
| Grifols USA, LLC | $207.93 | 2019-2024 | Prolastin-C Liquid |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $204.63 | 2019-2025 | |
| Idorsia Pharmaceuticals US INC | $200.59 | 2022-2024 | Quviviq |
| Eisai INC. | $181.12 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $135.88 | 2019-2023 | |
| Lilly USA, LLC | $117.01 | 2022-2025 | Zepbound, Mounjaro |
| Genentech USA, INC. | $109.26 | 2019-2020 | |
| Cipher Pharmaceuticals US LLC | $106.90 | 2025 | Natroba, Spinosad |
| Amgen INC. | $90.16 | 2021-2025 | Uplizna, Repatha |
| Novo Nordisk INC | $87.45 | 2025 | Ozempic |
| Inogen, INC. | $80.52 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Baxter Healthcare | $79.00 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $78.05 | 2020-2021 | |
| Electromed, INC. | $64.82 | 2022 | |
| Paratek Pharmaceuticals, INC. | $62.18 | 2023 | Nuzyra |
| Csl Behring | $59.84 | 2019-2020 | |
| Vapotherm INC | $58.86 | 2022 | |
| United Therapeutics Corporation | $51.92 | 2019-2023 | Tyvaso |
| Dexcom, INC. | $50.21 | 2025 | Dexcom G6 Transmitter |
| Almatica Pharma LLC | $46.51 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.76 | 2019 | |
| Allergan, INC. | $40.65 | 2019-2020 | |
| Axsome Therapeutics, INC. | $40.27 | 2023 | Sunosi |
| Verona Pharma, INC. | $30.20 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $29.65 | 2019-2020 | |
| 3b Medical, INC. | $29.40 | 2024-2025 | Luna |
| Merck Sharp & Dohme LLC | $27.67 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $24.64 | 2024 | Lumryz |
| Breas Medical, INC. | $23.87 | 2024 | Vivo 45 Ls |
| Pulmonx Corporation | $22.84 | 2022 | |
| Shire North American Group INC | $19.90 | 2019 | |
| Horizon Therapeutics Plc | $19.15 | 2020 | |
| Viatris Specialty LLC | $18.34 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $16.39 | 2025 | |
| Gilead Sciences, INC. | $16.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.32 | 2019 | |
| Aytu Biopharma, INC. | $14.59 | 2020 | |
| Circassia INC. | $13.85 | 2020 | |
| Sandoz INC. | $13.70 | 2022 | |
| Nabriva Therapeutics, Plc | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Cosmo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.